OPTINOSE INC. - COMMON STOCK

Optinose Announces Positive Top-line Results of ReOpen2, its second Phase 3 Clinical Trial of XHANCE for Treatment of Chronic Sinusitis

13 6 2022 06:00:01 提供 Nasdaq GlobeNewswire

Optinose Announces Departure of Chief Financial Officer

03 6 2022 06:00:37 提供 Nasdaq GlobeNewswire

Optinose Reports First Quarter 2022 Financial Results and Operational Updates

12 5 2022 06:00:19 提供 Nasdaq GlobeNewswire

Optinose Announces Reporting Date for First Quarter 2022 Financial Results

05 5 2022 16:00:00 提供 Nasdaq GlobeNewswire

Optinose Announces Appointment of R. John Fletcher to the Board

26 4 2022 07:00:03 提供 Nasdaq GlobeNewswire

Optinose to Present at the Needham Virtual Healthcare Conference

08 4 2022 07:30:00 提供 Nasdaq GlobeNewswire

Optinose Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Highlights

08 3 2022 06:00:01 提供 Nasdaq GlobeNewswire

Optinose Reports Positive Top-line Results in ReOpen1, a Landmark Phase 3 Trial for XHANCE in Chronic Sinusitis

07 3 2022 06:00:01 提供 Nasdaq GlobeNewswire

Optinose Announces Reporting Date for Fourth Quarter 2021 Financial Results

04 3 2022 13:00:00 提供 Nasdaq GlobeNewswire

Optinose Announces Appointment of Two New Members to Board of Directors

13 12 2021 06:54:10 提供 Nasdaq GlobeNewswire

Optinose to Present at the Piper Sandler Virtual Healthcare Conference

23 11 2021 06:00:00 提供 Nasdaq GlobeNewswire

Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

18 11 2021 15:30:00 提供 Nasdaq GlobeNewswire

Optinose Announces Closing of $46.0 Million Public Offering of Common Stock

18 11 2021 13:00:00 提供 Nasdaq GlobeNewswire

Optinose Announces Pricing of Public Offering of Common Stock

16 11 2021 07:01:59 提供 Nasdaq GlobeNewswire

Optinose Announces Proposed Public Offering of Common Stock

15 11 2021 16:40:53 提供 Nasdaq GlobeNewswire

Optinose Reports Third Quarter 2021 Financial Results and Recent Operational Highlights

15 11 2021 15:26:45 提供 Nasdaq GlobeNewswire

Optinose Announces Reporting Date for Third Quarter 2021 Financial Results

10 11 2021 16:50:01 提供 Nasdaq GlobeNewswire

Optinose Completes Patient Recruitment in Second Pivotal Trial for XHANCE in Chronic Sinusitis

28 10 2021 05:59:00 提供 Nasdaq GlobeNewswire

Optinose to Present at the Cantor Virtual Global Healthcare Conference

22 9 2021 15:15:00 提供 Nasdaq GlobeNewswire

Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

25 8 2021 16:00:00 提供 Nasdaq GlobeNewswire